BUTITTA CYNTHIA M 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 19, 2020
Insider Transaction Report
Form 4
BUTITTA CYNTHIA M
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-16−83,876→ 0 totalExercise: $4.41Exp: 2030-08-11→ Common Stock (83,876 underlying) - Exercise/Conversion
Common Stock
2020-09-16$4.41/sh+83,876$369,558→ 83,876 total - Award
Stock Option (Right to Buy)
2020-08-12+83,876→ 83,876 totalExercise: $4.41Exp: 2030-08-11→ Common Stock (83,876 underlying) - Award
Stock Option (Right to Buy)
2020-11-18+21,520→ 21,520 totalExercise: $19.00Exp: 2030-11-17→ Common Stock (21,520 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest in a series of 36 successive equal monthly installments measured from August 12, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
- [F2]The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.